Clinical Trials Directory

Trials / Unknown

UnknownNCT02545062

MoCa Test for the Early Detection of Mild Cognitive Impairment During Annual Assessment of Young Adults With Diabetes and in a Control Group Without Diabetes

Early Detection of Mild Cognitive Impairment in Young Diabetes Patients Using the MoCa Test

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
170 (estimated)
Sponsor
Clalit Health Services · Academic / Other
Sex
All
Age
20 Years – 55 Years
Healthy volunteers
Accepted

Summary

T2D and cognitive impairment are two of the most common chronic condition found in persons 60 years and older. Diabetes type 2 increases with age and studies suggest that the diabetes is one of the risk factor for cognitive impairment and dementia. Although there is much recent research showing that diabetics at every age have more cognitive impairment and dementia than non-diabetics, relatively little attention has been paid to the implications of this complication in the management of T2D in terms of screening, prevention, education and treatment adherence. There are now guidelines for periodic evaluation of patients with diabetes as early detection of complications of the disease, but so far there are no similar assessment and monitoring of cognitive function. In this study the investigators examine cognitive function in young diabetic patients (from 20 to 55) using the MoCa test, that allows detection of mild cognitive impairment, and may be carried out during a visit, an annual advisory diabetes clinic.

Detailed description

1. Patients on a routine visit to the diabetes clinic, who meet the inclusion criteria, will be recruited for the test. They will be given an explanation of the study and the questionnaire by the principal investigator. 2. Sign a consent form. 3. Performance and execution of MOCA test: * Fingerstick blood glucose for pre-cognitive testing performed (to avoid testing any participant with a serum glucose \< 70 mg/dl); * In the presence of hypoglycemia, the participant should be given a snack and begin the test only after the glucose level rises. Alternatively delay executing the Test 4. Details from the patient's file are registered, such as: duration of the disease, family history, presence of macro and micro vascular complications, lifestyle, years of education, and the results of relevant laboratory accuracy. 5. For each patient a medical file is opened containing the initials and serial number of his research. All results are then encoded and analyzed anonymously

Conditions

Interventions

TypeNameDescription
OTHERMoCa testThe MoCa test is actually used for the screening of Mild Cognitive Impairment . It is a one page 30 points test that can be done in 10 minutes in a routine annual visit to the Diabetes Clinic. The MoCa assesses several cognitive domains, and it is available in hebrew language.

Timeline

Start date
2014-05-01
Primary completion
2016-08-01
Completion
2016-08-01
First posted
2015-09-09
Last updated
2015-09-11

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02545062. Inclusion in this directory is not an endorsement.